Business
business

The end of de minimis could mean the end of cheap clothing imports

As of one minute past midnight today, the de minimis exemption on small packages shipped to the US officially ended.

While Corporate America has been obsessing over the effects of President Trump’s tariffs for months, many Americans might not have yet felt any direct impact of the more stringent trade policies of the new administration.

After today that might change.

The de minimis rule allowed small shipments of goods worth less than $800 to enter the US duty free, saving time on inspections and paperwork. Now, millions of packages coming into the country will be subject to the same tariffs applied to general goods — which in the case of shipments from China means a 145% fee.

In the last fiscal year alone, 1.36 billion packages entered the US under the de minimis exemption, per the US Customs and Border Protection Agency. That’s roughly five packages for every adult in America.

Closing the shipping loophole will affect retailers of every size, but cheap Chinese sellers like Temu and Shein will be particularly affected — and the change in regulation could spell the end of cheap clothing imports to the US. Historically, clothing (or apparel) has been an anomaly in the Consumer Price Index as one of few categories that has bucked the trend of consistently rising prices since the 1990s.

Apparel chart CPI index
Sherwood News

Data from the Bureau of Labor Statistics shows that while consumer prices for all items grew more than 13x from 1950 to 2024, apparel prices have grown only ~3x over that same period. In fact, from 1994 to 2024, apparel prices in the US actually fell 1%.

The de minimis rule allowed small shipments of goods worth less than $800 to enter the US duty free, saving time on inspections and paperwork. Now, millions of packages coming into the country will be subject to the same tariffs applied to general goods — which in the case of shipments from China means a 145% fee.

In the last fiscal year alone, 1.36 billion packages entered the US under the de minimis exemption, per the US Customs and Border Protection Agency. That’s roughly five packages for every adult in America.

Closing the shipping loophole will affect retailers of every size, but cheap Chinese sellers like Temu and Shein will be particularly affected — and the change in regulation could spell the end of cheap clothing imports to the US. Historically, clothing (or apparel) has been an anomaly in the Consumer Price Index as one of few categories that has bucked the trend of consistently rising prices since the 1990s.

Apparel chart CPI index
Sherwood News

Data from the Bureau of Labor Statistics shows that while consumer prices for all items grew more than 13x from 1950 to 2024, apparel prices have grown only ~3x over that same period. In fact, from 1994 to 2024, apparel prices in the US actually fell 1%.

More Business

See all Business
Strive Pharmacy recently broke ground on a new facility in Mesa, Arizona. (Strive Pharmacy)

Before Hims’ GLP-1 pill fallout, its pharmacy partner was already drawing scrutiny from state regulators

Strive has already been probed over the timing of its GLP-1 compounding. Now, Arizona regulators are looking into complaints about ketamine misuse and improper distribution of prescription drugs.

business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.